Abstract:Alport syndrome (AS) is an inherited progressive disease caused by mutations in genes encoding for the 3, 4 and 5 chains, which are an essential component of type IV collagen and are required for formation of the glomerular basement membrane. However, the underlying etiology of AS remains largely unknown, and the aim of the present study was to examine the genetic mechanisms in AS. Induced pluripotent stem cells (iPSCs) were generated from renal tubular cells. The Illumina HiSeq 2000 system and iTRAQ-coupled 2D liquid chromatography-tandem mass spectrometry were used to generate the sequences of microRNAs (miRNAs), transcripts and proteins from AS-iPSCs. Integration of miRNA, transcript and protein expression data was used to construct regulatory networks and identify specific miRNA targets amongst the transcripts and proteins. Relative quantitative proteomics using iTRAQ technology revealed 383 differentially abundant proteins, and high-throughput sequencing identified 155 differentially expressed miRNAs and 1,168 differentially expressed transcripts. Potential miRNA targets were predicted using miRanda, TargetScan and Pictar. All target proteins and transcripts were subjected to network analysis with miRNAs. Gene ontology analysis of the miRNAs and their targets revealed functional information on the iPSCs, including biological process and cell signaling. Kyoto Encyclopedia of Genes and Genomes pathways analysis revealed that the transcripts and proteins were primarily enriched in metabolic and cell adhesion molecule pathways. In addition, the network maps identified hsa-miRNA (miR)-4775 as a prominent miRNA that was associated with a number of targets. Similarly, the prominent ELV-like protein 1-A and epidermal growth factor receptor (EGFR)-associated transcripts were identified. Reverse transcription-quantitative polymerase chain reaction analysis was used to confirm the upregulation of hsa-miR-4775 and EGFR. The integrated approach used in the present study provided a comprehensive molecular characterization of AS. The results may also further understanding of the genetic pathogenesis of AS and facilitate the identification of candidate biomarkers for AS.

Effects of age and tissue types on X-inactivation patterns in females with X-linked Alport syndrome

Correlation between X-Inactivation of Different Tissues and Phenotypes in Female with X-Linked Alport Syndrome

Correlation Between Mrna Expression Level of the Mutant COL4A5 Gene and Phenotypes of XLAS Females.

Genetic features and kidney morphological changes in women with X-linked Alport syndrome

Genotype and X-chromosome inactivation are associated with disease severity in females with X-linked Alport syndrome

Effect of Heterozygous Pathogenic COL4A3 or COL4A4 Variants on Patients with X-linked Alport Syndrome.

Dissecting the genotype-phenotype correlation of <i>COL4A5</i> gene mutation and its response to renin-angiotensin-aldosterone system blockers in Chinese male patients with Alport syndrome

Comparison of phenotypic features between patients with X-linked and autosomal recessive Alport syndrome

[Features of Clinical Phenotype and Genotype in Alport Syndrome: a Monocentric Study].

A comparison of phenotypic features in patients of X-linked and autosomal recessive Alport syndrome

Clinical and genetic features of X-linked Alport syndrome in men positive for the collagen Ⅳ α5 chain in epidermal basement membrane]

Analyzing three pedigrees in X-linked Alport syndrome with the presentation of nephrotic syndrome

[Follow-Up Study on the Pregnancy of an X-linked Dominant Alport Syndrome Female].

Prenatal Diagnosis And Genetic Counseling Of A Chinese Alport Syndrome Kindred

Endoplasmic Reticulum Stress Activation in Alport Syndrome Varies Between Genotype and Cell Type

Attitudes Toward Genetic Diagnosis and Prenatal Diagnosis of X‐linked Alport Syndrome in China

Alport Syndrome —— an Analysis of 22 Families

[Clinical and Pathological Study of 47 Cases with Alport Syndrome].

Spectrum of Clinical Features and Type IV Collagen Alpha-Chain Distribution in Chinese Patients with Alport Syndrome.

A Clinicopathological Study of Alport Syndrome and Detection of Type IV Collagen Chains in Alport Patients.

Establishment of Microrna, Transcript and Protein Regulatory Networks in Alport Syndrome Induced Pluripotent Stem Cells